Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India

Kumar, Rishikesh and Kamath, Asha and Hande, Manjunath H and Vidyasagar, Sudha and Acharya, Raviraja and Acharya, Vasudeva and Belle, Jayaprakash and Shastry, Ananthakrishna Barkur and Saravu, Kavitha (2015) Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India. Malaria Journal, 14 (310). pp. 1-6.

[img] PDF
e-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.pdf - Published Version
Restricted to Registered users only

Download (1MB) | Request a copy

Abstract

Background: Of late there have been accounts of therapeutic failure and chloroquine resistance in Plasmodium vivax malaria especially from Southeast Asian regions. The present study was conducted to assess the therapeutic efficacy of chloroquine–primaquine (CQ–PQ) combined regimen in a cohort of uncomplicated P. vivax mono-infection. Methods: A tertiary care hospital-based prospective study was conducted among adult cohort with mono-infection P. vivax malaria as per the World Health Organization’s protocol of in vivo assessment of anti-malarial therapeutic efficacy. Participants were treated with CQ 25 mg/kg body weight divided over 3 days and PQ 0.25 mg/kg body weight daily for 2 weeks. Results: Of a total of 125 participants recruited, 122 (97.6%) completed day 28 follow up, three (2.4%) participants were lost to follow-up. Eight patients (6.4%) were ascertained to have mixed P. vivax and Plasmodium falciparum infection by nested polymerase chain reaction test. The majority of subjects (56.8%, 71/125) became aparasitaemic on day 2 followed by 35.2% (44/125) on day 3, and 8% (10/125) on day 7, and remained so thereafter. Overall only one therapeutic failure (0.8%, 1/125) occurred on day 3 due to persistence of fever and parasitaemia. Conclusions: CQ–PQ combined regimen remains outstandingly effective for uncomplicated P. vivax malaria and should be retained as treatment of choice in the study region. One case of treatment failure indicates possible resistance which warrants constant vigilance and periodic surveillance.

Item Type: Article
Uncontrolled Keywords: Malaria; plasmodium vivax; anti-malarials; treatment failure; chloroquine; primaquine.
Subjects: Medicine > KMC Manipal > Medicine
Depositing User: KMC Library
Date Deposited: 24 Sep 2015 11:27
Last Modified: 24 Sep 2015 11:27
URI: http://eprints.manipal.edu/id/eprint/144089

Actions (login required)

View Item View Item